Anti-AFP Antibody and Daunorubicin Conjugate Suppresses Tumor Growth
Author Information
Author(s): Y. Tsukada, K. Ohkawa, N. Hibi
Primary Institution: Hokkaido University School of Medicine
Hypothesis
Can an anti-alpha-fetoprotein antibody-daunorubicin conjugate effectively suppress the growth of human hepatocellular carcinoma in nude mice?
Conclusion
The aAFP-PLGA-DM conjugate shows potent anti-tumor activity against human AFP-producing tumors in nude mice.
Supporting Evidence
- The conjugate showed a significant reduction in tumor growth compared to control groups.
- Serum AFP levels were significantly lower in mice treated with the conjugate.
- The study demonstrated that the conjugate effectively targeted AFP-producing tumors.
Takeaway
Researchers created a special medicine that combines an antibody with a cancer drug to help stop a type of liver cancer from growing in mice.
Methodology
The study involved treating nude mice with a conjugate of anti-AFP antibody and daunorubicin, measuring tumor growth and serum AFP levels.
Limitations
The study was conducted in nude mice, which may not fully represent human responses.
Participant Demographics
Nude mice were used in the study.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website